Skip to main content

Strategic Blueprint, LLC

Position in ABT — Abbott Laboratories

CIK 1767821 ATLANTA, GA

Position in ABT

as of Jun 30, 2026 · filed Jul 23, 2026
Position Value
$392,904
-$27,118 QoQ
Shares Held
4,330
+5.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#2,073
of 2,959 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ABT Over Time

Shares Held

Position Value (USD)

Derivatives in ABT

reported options exposure · as of Mar 31, 2021
CallValue
$239,680
CallShares
2,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Jun 30, 2026

Strategic Blueprint, LLC holds $908,640 across 3 Medical Devices names. ABT ranks #1 (43.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABT
Abbott Laboratories
This page
4,330 $392,904

All Filings in ABT

Export CSV
27 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $392,904 4,330
2026-03-31 $420,022 4,091
2025-12-31 $499,280 3,985
2025-09-30 $659,520 4,924
2025-06-30 $849,110 6,243
2025-03-31 $472,366 3,561
2024-12-31 $347,360 3,071
2024-09-30 $375,206 3,291
2024-06-30 $529,629 5,097
2024-03-31 $552,728 4,863
2023-12-31 $932,843 8,475
2023-09-30 $797,559 8,235
2023-06-30 $866,599 7,949
2023-03-31 $832,053 8,217
2022-12-31 $922,894 8,406
2022-09-30 $1,272,490 13,151
2022-06-30 $1,352,583 12,449
2022-03-31 $1,454,762 12,291
2021-12-31 $1,861,427 13,226
2021-09-30 $1,464,930 12,401
2021-06-30 $2,698,618 23,278
2021-03-31 $239,680 2,000
2021-03-31 $4,116,264 34,348
2020-12-31 $3,571,673 32,621
2020-09-30 $5,221,119 47,975
2020-06-30 $3,170,518 34,677
2020-03-31 $1,894,944 24,014